Hepatology

Medical research

Scientists create most sophisticated human liver model yet

Scientists at Wake Forest Institute for Regenerative Medicine (WFIRM) have developed the most sophisticated mini-livers to date. These organoids can potentially help scientists better understand certain congenital liver diseases ...

Diseases, Conditions, Syndromes

Initial successes in treating a hitherto incurable liver disorder

Primary sclerosing cholangitis is a currently incurable liver disorder, primarily affecting younger adults aged between 30 and 40. A European multi-centre Phase II study led by MedUni Vienna in close collaboration with MedUni ...

Diseases, Conditions, Syndromes

Modified protein reverses cirrhosis in lab rats

A protein modified to increase the amount of time it circulates in the bloodstream appears to reverse liver fibrosis and cirrhosis in rats, according to results of a study led by Johns Hopkins researchers.

Diseases, Conditions, Syndromes

EHR-based prompt ups hepatitis C screening for baby boomers

(HealthDay)—Implementation of an electronic health record (EHR)-based prompt can improve hepatitis C virus (HCV) screening rates among baby boomers, according to a study published online July 17 in Hepatology.

Diseases, Conditions, Syndromes

Factors ID'd to predict fatty liver in obese teens

(HealthDay)—Ethnicity/race, markers of insulin resistance, and genetic factors might help identify obese youth at risk for developing fatty liver, according to a study published online April 17 in Hepatology.

Diseases, Conditions, Syndromes

In acetaminophen-induced acute liver failure, FABP1 IDs mortality

(HealthDay)—Serum liver-type fatty acid binding protein (FABP1) early (day one) or late (day three to five) levels are associated with mortality in patients with acetaminophen (APAP)-induced acute liver failure (ALF), according ...

Diseases, Conditions, Syndromes

Guidelines updated for diagnosis, management of NAFLD

(HealthDay)—A practice guidance statement, published online July 17 in Hepatology, has been developed to augment the clinical practice guidelines for the diagnosis and management of non-alcoholic fatty liver disease (NAFLD).

page 6 from 16